↓ Skip to main content

Renal Effects of SGLT‐2 Inhibitors and Other Anti‐diabetic Drugs: Clinical Relevance and Potential Risks

Overview of attention for article published in Clinical Pharmacology & Therapeutics, July 2017
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
45 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Renal Effects of SGLT‐2 Inhibitors and Other Anti‐diabetic Drugs: Clinical Relevance and Potential Risks
Published in
Clinical Pharmacology & Therapeutics, July 2017
DOI 10.1002/cpt.731
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 45 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 45 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 10 22%
Student > Bachelor 5 11%
Student > Master 5 11%
Other 4 9%
Student > Doctoral Student 2 4%
Other 4 9%
Unknown 15 33%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 14 31%
Pharmacology, Toxicology and Pharmaceutical Science 9 20%
Biochemistry, Genetics and Molecular Biology 3 7%
Nursing and Health Professions 2 4%
Computer Science 1 2%
Other 1 2%
Unknown 15 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 August 2017.
All research outputs
#21,938,746
of 24,477,448 outputs
Outputs from Clinical Pharmacology & Therapeutics
#4,200
of 4,370 outputs
Outputs of similar age
#279,604
of 318,576 outputs
Outputs of similar age from Clinical Pharmacology & Therapeutics
#36
of 38 outputs
Altmetric has tracked 24,477,448 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,370 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.9. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 318,576 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 38 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.